Choose which optional cookies and similar storage we may use. Strictly necessary storage is always on, because the site cannot work without it.

Press kit

Facts, descriptions and logos for Gateway Global and its products, in one place. Please describe us the way we describe ourselves below.

Last updated

How to describe us

Please use these descriptions word for word.

One line

Gateway Global is a London AI company that builds AI for real work: patient calls, health intelligence, private AI processing and technical due diligence.

About 50 words

Gateway Global Ltd is an AI company headquartered in London. We build and run AI that does real work: Prime Assist, AI voice infrastructure for healthcare; Averra, a digital health twin in development; Prime Edge AI, which decides where each AI request is processed; and Gateway Assay, for code review and technical due diligence.

About 100 words

Gateway Global Ltd is an AI company headquartered in London. We build and run AI that does real work: Prime Assist, AI voice infrastructure for healthcare; Averra, a digital health twin in development; Prime Edge AI, which decides where each AI request is processed; and Gateway Assay, for code review and technical due diligence.

Our team includes clinicians and a Clinical Safety Officer, and Prime Assist has a clinical safety case under DCB0129, the NHS standard for clinical risk management. We have filed three UK patent applications, covering secure cloud computing, control over where AI requests can go, and voice AI orchestration. We also design and build AI for NHS and private healthcare organisations, clinicians, insurers and investors. From London, for the world.

About 200 words

Gateway Global Ltd is an AI company headquartered in London, founded in September 2023 by Omid Arbab. We build and run AI that does real work in production.

Our products include Prime Assist, AI voice infrastructure for healthcare that answers patient calls in several languages; Averra, an AI digital health twin, currently in development; Prime Edge AI, which answers routine requests on the device and sends harder ones to a frontier model in the cloud only when needed; and Gateway Assay, a code review and technical due diligence product for investors and acquirers.

Our team includes clinicians and a Clinical Safety Officer, and Prime Assist has a clinical safety case under DCB0129. We have filed three UK patent applications. We also design and build AI for NHS and private healthcare organisations, clinicians with ideas for new tools, insurers and health payers, and investors who need technical due diligence.

In 2026 we submitted written evidence to the House of Lords Science and Technology Committee on why UK small businesses find it hard to deploy technology into the NHS. Our aim is to help healthcare move from reactive to proactive. From London, for the world.

Our products in a paragraph

Prime Assist
AI voice infrastructure for healthcare. It answers patient calls in the caller's own language, so your team has time for the patients in front of them.
Averra
A digital twin of you. Private health intelligence, in development.
Prime Edge AI
Intelligence that knows where to think.
Gateway Assay
Know what you are buying before you sign.

Founder

Omid Arbab, Founder and Chief Executive Officer.

Draft (F20): Founder biography and approved photos, once Omid approves the wording and the photos.

[TO CONFIRM: approved biography and photos]

Logos

Use the white wordmark on dark grounds and the black wordmark on light grounds. Please do not redraw, recolour or stretch the mark.

Draft (E5): SVG masters of the full lockup, and approved product images.

Lockup SVG masters; product images.

Brand colours

  • Mark violet #8030C5The dotted-ring mark only
  • Accent #6A1FC0Buttons and highlights
  • Ink #0A0A10Text on light grounds
  • Ground #E8E8ECLight page ground

Press contact

Draft (D1): Press contact (press@ mailbox or Assist@).

[TO CONFIRM: press contact]

Contact the press team